The 2016 Emerging Medical Technologies Report is a unique resource for investors, market researchers, and business development executives seeking discreet and detailed business, market, and competitive intelligence on early stage medical technology companies. It is the premier tool for identifying and tracking emerging companies in the medtech space. The 2016 Report covers over 1,000 early stage medical device companies that either presented at LSI's 2015 Emerging Medical Technology Summit or that were profiled by LSI's research team within the last 12 months. In addition to detailed company profiles, the 2016 Report also provides deals data including financing events and M&A activity -- focused exclusively on early stage medtech transactions.
Purchase this report today and get:
Profiles of Private Medtech Companies
Identify disruptive medtech companies that may be M&A, licensing or investment targets. Use this tool as a one-stop resource to identify the formation of privately-held, early stage medtech companies.
Deals Data Focused on Early Stage Medtech
Up-to-date information on deals being made in the medtech space including M&A activity, investments, IPOs, and licensing deals.
Profiles (1,000 companies)
This Report includes profiles of early stage medtech companies that presented at LSI's 2015 Emerging Medical Technology Summit or that were profiled by LSI's research team within the last 12 months.
The following information is included in the company profiles for over 1,000 companies:
• Business Summary
• Technology Details
• Target Markets
• Regulatory/Development Status
• Public Filings
• Key Management
• Other Company Information
In addition, extended Executive Summaries for 200 key early-stage movers & shakers (identified by LSI analysts as ones to watch for) are also included. The extended Executive Summaries include details on each company's business plans, technology details and differentiation, market strategy, investment needs, and plans for growth.
Deals Data (371 transactions)
371 deal records (representing over $16B in activity) are included for transactions occurring in 2015. Deal records include information on investments, M&A, IPO and licensing activity related specifically to early stage medtech companies. This information is ideal for benchmarking valuations, identifying investment trends and opportunities, and gaining a clear picture of the current medtech IPO and M&A markets.